Skip to main content
VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
3.155
+0.025 (0.80%)
At close: Nov 7, 2024, 4:00 PM
3.110
-0.045 (-1.43%)
After-hours: Nov 7, 2024, 6:01 PM EST

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $198.00K in the quarter ending June 30, 2024, with 46.67% growth. This brings the company's revenue in the last twelve months to $486.00K, up 19.41% year-over-year. In the year 2023, VYNE Therapeutics had annual revenue of $424.00K, down -11.11%.

Revenue (ttm)
$486.00K
Revenue Growth
+19.41%
P/S Ratio
192.78
Revenue / Employee
$49,300
Employees
10
Market Cap
46.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023424.00K-53.00K-11.11%
Dec 31, 2022477.00K-454.00K-48.76%
Dec 31, 2021931.00K-20.06M-95.57%
Dec 31, 202020.99M20.55M4,638.83%
Dec 31, 2019443.00K-3.15M-87.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SHL Telemedicine 55.94M
HOOKIPA Pharma 52.16M
Carisma Therapeutics 20.71M
Accelerate Diagnostics 12.23M
Serina Therapeutics 3.17M
CollPlant Biotechnologies 689.00K
Revenue Rankings

VYNE News

More News